BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 30771597)

  • 21. Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation.
    Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Mallat MJ; Haasnoot GW; van Zwet EW; Claas EC; de Fijter JW; Kroes AC; Arnold F; Touzé A; Claas FH; Rotmans JI; Feltkamp MC
    Am J Transplant; 2017 Jan; 17(1):161-172. PubMed ID: 27251361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
    Knight RJ; Gaber LW; Patel SJ; DeVos JM; Moore LW; Gaber AO
    Transplantation; 2013 Apr; 95(7):949-54. PubMed ID: 23545506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and evaluation of a BK polyomavirus serotyping assay using Luminex technology.
    Wunderink HF; de Brouwer CS; van der Meijden E; Pastrana DV; Kroes ACM; Buck CB; Feltkamp MCW
    J Clin Virol; 2019 Jan; 110():22-28. PubMed ID: 30529638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous BK Polyomavirus (BKPyV)-associated nephropathy and hemorrhagic cystitis after living donor kidney transplantation.
    Helanterä I; Hirsch HH; Wernli M; Ortiz F; Lempinen M; Räisänen-Sokolowski A; Auvinen E; Mannonen L; Lautenschlager I
    J Clin Virol; 2016 Mar; 76():4-7. PubMed ID: 26771744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A kidney transplant recipient with renal medullary viral cytopathic changes.
    Ramanan P; Timmerman EA; Fidler ME; Amer H; Pritt BS; Schwab DA; Batterman HJ; Binnicker MJ
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27925350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BK polyomavirus infection after renal transplantation: Surveillance in a resource-challenged setting.
    Bagchi S; Gopalakrishnan V; Srivastava SK; Upadhayay A; Singh G; Bhowmik D; Mahajan S; Dinda A; Agarwal SK
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28834032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for BK virus viremia and nephropathy after kidney transplantation: A systematic review.
    Demey B; Tinez C; François C; Helle F; Choukroun G; Duverlie G; Castelain S; Brochot E
    J Clin Virol; 2018 Dec; 109():6-12. PubMed ID: 30343190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
    Mohamed M; Parajuli S; Muth B; Astor BC; Panzer SE; Mandelbrot D; Zhong W; Djamali A
    Transpl Infect Dis; 2016 Jun; 18(3):361-71. PubMed ID: 26998753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients.
    Abudayyeh A; Hamdi A; Abdelrahim M; Lin H; Page VD; Rondon G; Andersson BS; Afrough A; Martinez CS; Tarrand JJ; Kontoyiannis DP; Marin D; Gaber AO; Oran B; Chemaly RF; Ahmed S; Abudayyeh I; Olson A; Jones R; Popat U; Champlin RE; Shpall EJ; Rezvani K
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27862740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of HPyV9 and TSPyV coinfection on the development of BK polyomavirus viremia and associated nephropathy after kidney transplantation.
    van Rijn AL; Wunderink HF; de Brouwer CS; van der Meijden E; Rotmans JI; Feltkamp MCW
    J Med Virol; 2019 Jun; 91(6):1142-1147. PubMed ID: 30624811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence and isolated subtypes of BK polyomavirus reactivation among patients infected with human immunodeficiency virus-1 in southeastern China.
    Hu C; Huang Y; Su J; Wang M; Zhou Q; Zhu B
    Arch Virol; 2018 Jun; 163(6):1463-1468. PubMed ID: 29435709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The human polyomavirus BK (BKPyV): virological background and clinical implications.
    Rinaldo CH; Tylden GD; Sharma BN
    APMIS; 2013 Aug; 121(8):728-45. PubMed ID: 23782063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-E Polymorphism Determines Susceptibility to BK Virus Nephropathy after Living-Donor Kidney Transplant.
    Rohn H; Michita RT; Schramm S; Dolff S; Gäckler A; Korth J; Heinemann FM; Wilde B; Trilling M; Horn PA; Kribben A; Witzke O; Rebmann V
    Cells; 2019 Aug; 8(8):. PubMed ID: 31394776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Currently recommended BK virus (BKV) plasma viral load cutoff of ≥4 log10/mL underestimates the diagnosis of BKV-associated nephropathy: a single transplant center experience.
    Hassan S; Mittal C; Amer S; Khalid F; Patel A; Delbusto R; Samuel L; Alangaden G; Ramesh M
    Transpl Infect Dis; 2014 Feb; 16(1):55-60. PubMed ID: 24283677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BK and JC polyomavirus infections in Tunisian renal transplant recipients.
    Boukoum H; Nahdi I; Sahtout W; Skiri H; Aloui S; Achour A; Segondy M; Aouni M
    J Med Virol; 2015 Oct; 87(10):1788-95. PubMed ID: 25952258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of immune suppressive agents on the BK-Polyomavirus non coding control region.
    Korth J; Anastasiou OE; Verheyen J; Dickow J; Sertznig H; Frericks N; Bleekmann B; Kribben A; Brinkhoff A; Wilde B; Sutter K; Dittmer U; Ciesek S; Witzke O; Widera M
    Antiviral Res; 2018 Nov; 159():68-76. PubMed ID: 30268912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BK polyomavirus nephropathy in two kidney transplant patients with distinct diagnostic strategies for BK virus and similar clinical outcomes: two case reports.
    Gouvêa ALF; Cosendey RIJ; Nascimento ALR; Carvalho FR; Silva AA; de Moraes HP; Rochael MC; Varella RB; Almeida SG; Almeida JR; Lugon JR
    J Med Case Rep; 2017 May; 11(1):146. PubMed ID: 28535782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy.
    Bruminhent J; Srisala S; Klinmalai C; Pinsai S; Watcharananan SP; Kantachuvesiri S; Hongeng S; Apiwattanakul N
    BMC Infect Dis; 2019 Nov; 19(1):974. PubMed ID: 31744480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viral Origin, Clinical Course, and Renal Outcomes in Patients With BK Virus Infection After Living-Donor Renal Transplantation.
    Schwarz A; Linnenweber-Held S; Heim A; Framke T; Haller H; Schmitt C
    Transplantation; 2016 Apr; 100(4):844-53. PubMed ID: 26720302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The risk factors associated with post-transplantation BKPyV nephropathy and BKPyV DNAemia: a prospective study in kidney transplant recipients.
    Lorant C; Zigmantaviciute J; Ali N; Bonnevier U; Tejde M; von Zur-Mühlen B; Eriksson BM; Bergqvist A; Westman G
    BMC Infect Dis; 2024 Feb; 24(1):245. PubMed ID: 38388351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.